The Role of Ampligen in Strategic Therapeutic Intervention (STI) of Highly Active Anti-Retroviral Therapy (HAART): A Multi-Center, Randomized, Controlled Study of Ampligen Potentiation of the HAART-Free Interval.
Phase of Trial: Phase II
Latest Information Update: 16 Apr 2013
At a glance
- Drugs Rintatolimod (Primary)
- Indications HIV infections; HIV-1 infections
- Focus Therapeutic Use
- Sponsors Hemispherx Biopharma
- 13 Apr 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 26 Oct 2005 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History